Literature DB >> 10197815

Discordant expression of utrophin and its transcript in human and mouse skeletal muscles.

A O Gramolini1, G Karpati, B J Jasmin.   

Abstract

In order to determine the mechanisms regulating utrophin expression in human skeletal muscle, we examined the expression and distribution of utrophin and its transcript in biopsies from normal subjects as well as from Duchenne muscular dystrophy (DMD) and polymyositis (PM) patients. We first determined by immunoblotting that in comparison to biopsies from normal subjects, utrophin levels were indeed higher in muscle samples from both DMD and PM patients as previously shown. By contrast, levels of utrophin mRNAs as determined by both RT-PCR assays and in situ hybridization, were identical in muscle samples obtained from normal subjects versus DMD and PM patients. In these experiments, we also noted that while utrophin transcripts had a clear tendency to accumulate within the postsynaptic sarcoplasm of normal human muscle fibers, the extent of synaptic accumulation was considerably less than that which we recently observed in mouse muscle fibers. The distribution of utrophin transcripts in synaptic and extrasynaptic compartments of muscle fibers obtained from DMD and PM patients was similar to that seen along muscle fibers from normal subjects. Finally, we also monitored expression of utrophin and its transcripts during regeneration of mouse muscle induced to degenerate by cardiotoxin injections. In these regenerating muscles, we observed by both immunoblotting and immunofluorescence, a large increase (4- to 7-fold) in the levels of utrophin. In agreement with our results obtained with human muscle, the increase in utrophin levels in regenerating mouse muscle was not accompanied by parallel changes in the abundance of utrophin transcripts. Taken together, these results indicate that the levels of utrophin and its transcript in muscle are discordantly regulated under certain conditions thereby highlighting the important contribution of post-transcriptional regulatory mechanisms in the control of utrophin levels in skeletal muscle fibers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197815     DOI: 10.1097/00005072-199903000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  18 in total

1.  Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice.

Authors:  Alison R Amenta; Atilgan Yilmaz; Sasha Bogdanovich; Beth A McKechnie; Mehrdad Abedi; Tejvir S Khurana; Justin R Fallon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 2.  Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances.

Authors:  Guy L Odom; Paul Gregorevic; Jeffrey S Chamberlain
Journal:  Biochim Biophys Acta       Date:  2006-09-26

3.  CT-GalNAc transferase overexpression in adult mice is associated with extrasynaptic utrophin in skeletal muscle fibres.

Authors:  Margaret Durko; Carol Allen; Josephine Nalbantoglu; George Karpati
Journal:  J Muscle Res Cell Motil       Date:  2010-08-13       Impact factor: 2.698

4.  Poly C Binding Protein 2 dependent nuclear retention of the utrophin-A mRNA in C2C12 cells.

Authors:  Gargi Ghosh; Satyabrata Samui; Santanu Das; Vandana Singh; Doel Pal; Subhanwita Das; Jishu Naskar; Soumya Sinha Roy; Utpal Basu
Journal:  RNA Biol       Date:  2021-12-14       Impact factor: 4.652

5.  Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.

Authors:  Paul T Martin; G Diane Shelton; Peter J Dickinson; Beverly K Sturges; Rui Xu; Richard A LeCouteur; Ling T Guo; Robert A Grahn; Harriet P Lo; Kathryn N North; Richard Malik; Eva Engvall; Leslie A Lyons
Journal:  Neuromuscul Disord       Date:  2008-11-05       Impact factor: 4.296

6.  Brain-derived neurotrophic factor regulates satellite cell differentiation and skeltal muscle regeneration.

Authors:  Charlene Clow; Bernard J Jasmin
Journal:  Mol Biol Cell       Date:  2010-04-28       Impact factor: 4.138

Review 7.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

8.  Oral quercetin administration transiently protects respiratory function in dystrophin-deficient mice.

Authors:  Joshua T Selsby; Christopher G Ballmann; Hannah R Spaulding; Jason W Ross; John C Quindry
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

9.  Ets-2 repressor factor silences extrasynaptic utrophin by N-box mediated repression in skeletal muscle.

Authors:  Kelly J Perkins; Utpal Basu; Murat T Budak; Caroline Ketterer; Santhosh M Baby; Olga Lozynska; John A Lunde; Bernard J Jasmin; Neal A Rubinstein; Tejvir S Khurana
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

10.  Mouse regenerating myofibers detected as false-positive donor myofibers with anti-human spectrin.

Authors:  Anete Rozkalne; Carl Adkin; Jinhong Meng; Ariya Lapan; Jennifer E Morgan; Emanuela Gussoni
Journal:  Hum Gene Ther       Date:  2013-12-19       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.